Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

National Institute of Mental Health, Dhaka

🇧🇩Bangladesh

Country: 🇧🇩Bangladesh

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)

Phase 1

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Drug: Intravenous Ethanol
Drug: 18F-PF-06445974

First Posted Date: 2025-06-19

Last Posted Date: 2025-07-03

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 30

Registration Number: NCT07027839

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Phase 1

Recruiting

Conditions: Long COVID
Post Acute Sequelae of COVID-19

Interventions: Drug: 11C-PS13

First Posted Date: 2025-04-10

Last Posted Date: 2025-06-24

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 60

Registration Number: NCT06920628

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Phase 1

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Drug: 18F-PF-06445974

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-26

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 30

Registration Number: NCT06795581

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: 11C-JMJ-129

First Posted Date: 2025-03-13

Last Posted Date: 2025-05-31

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 40

Registration Number: NCT06874205

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety

Phase 2

Recruiting

Conditions: Psychiatric Disorders
Anxiety Disorders

Interventions: Behavioral: Gaze-Contingent Music Reward Therapy

First Posted Date: 2024-09-19

Last Posted Date: 2025-07-02

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 150

Registration Number: NCT06595953

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Phase 2

Recruiting

Conditions: Suicide
Depressive Disorder, Treatment-Resistant
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Excitatory Amino Acid Agents
Ketamine
Physiological Effects of Drugs
Depressive Disorder, Major
Mental Disorders
Mood Disorders

Interventions: Drug: (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg)
Drug: Placebo

First Posted Date: 2024-07-22

Last Posted Date: 2025-06-22

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 50

Registration Number: NCT06511908

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers

Early Phase 1

Recruiting

Conditions: Irritability

Interventions: Other: Frustration task

First Posted Date: 2024-07-03

Last Posted Date: 2025-06-13

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 80

Registration Number: NCT06484088

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸
Texas A&M University, College Station, Texas, United States

Natural History of Depression, Bipolar Disorder and Suicide Risk

Recruiting

Conditions: Excitatory Amino Acid Agents
Molecular Mechanisms of Pharmacological Action
Anesthetics, Dissociative
Behavioral Symptoms
Suicide
Self-Injurious Behavior
Anesthetics
Depression, Unipolar
Depressive Symptoms
Depression, Bipolar

First Posted Date: 2024-06-17

Last Posted Date: 2025-07-02

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 500

Registration Number: NCT06462196

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Efficacy of Mirtazapine in Major Depressive Disorder With Insomnia

Phase 4

Completed

Conditions: Major Depressive Disorder With Insomnia

Interventions: Drug: Mirtazapine Tablets

First Posted Date: 2023-08-07

Last Posted Date: 2024-04-02

Lead Sponsor: National Institute of Mental Health, Dhaka

Target Recruit Count: 135

Registration Number: NCT05978219

Locations: 🇧🇩
National Institute of Mental Health, Dhaka, Bangladesh

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Phase 1

Recruiting

Conditions: Depression

Interventions: Radiation: Lung scan
Drug: Apremilast
Drug: 18F-PF-06445974

First Posted Date: 2023-01-30

Last Posted Date: 2025-03-27

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 108

Registration Number: NCT05703685

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy